For intestinal conditions like Crohn's disease, oral KPV provides direct mucosal contact which may enhance local anti-inflammatory effects. Subcutaneous administration offers systemic benefits. Some protocols use both routes for comprehensive coverage of gut and extraintestinal manifestations.
KPV inflammatory bowel disease research